| 2024-04-01 17:28 | CC:PMN | ProMIS Neurosciences Inc. | | SEDAR Annual Report803 | SEDAR Annual Report |
| 2024-04-01 17:27 | CC:PMN | ProMIS Neurosciences Inc. | | SEDAR MD & A815 | SEDAR MD & A |
| 2024-04-01 17:21 | CC:PMN | ProMIS Neurosciences Inc. | | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2024-01-22 10:35 | CC:PMN | Promis Neurosciences Inc (2) | | News Release200 | Promis selects lead vaccine candidate PMN400 |
| 2024-01-08 10:15 | CC:PMN | Promis Neurosciences Inc (2) | 6.00 | Shareholders Letter212 | Promis CEO talks drug candidates in shareholders letter |
| 2023-12-20 09:53 | CC:PMN | Promis Neurosciences Inc (2) | 6.00 | News Release200 | Promis publishes article on ALS, FTLD protein target |
| 2023-11-14 18:04 | CC:PMN | ProMIS Neurosciences Inc. | 6.00 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-11-14 18:02 | CC:PMN | ProMIS Neurosciences Inc. | 6.00 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-11-14 16:57 | CC:PMN | Promis Neurosciences Inc (2) | 6.00 | News Release200 | Promis has Sept. 30 cash position of $16.86M (U.S.) |
| 2023-08-21 16:25 | CC:PMN | Promis Neurosciences Inc (2) | 6.00 | News Release200 | Promis arranges $20.4-million private placement |
| 2023-08-14 18:14 | CC:PMN | ProMIS Neurosciences Inc. | 6.00 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-07-17 09:49 | CC:PMN | Promis Neurosciences Inc (2) | 7.60 | News Release200 | Promis details PMN310 preclinical data at AAIC 2023 |
| 2023-07-14 09:49 | CC:PMN | Promis Neurosciences Inc (2) | 3.65 | News Release200 | Promis Neurosciences completes continuance into Ontario |
| 2023-07-13 20:24 | CC:PMN | Promis Neurosciences Inc (2) | 3.65 | Shares Delisted from TSX222 | Promis Neurosciences to be delisted from TSX July 21 |
| 2023-07-10 09:47 | CC:PMN | Promis Neurosciences Inc (2) | 4.84 | News Release200 | Promis Neurosciences to delist from TSX |
| 2023-06-30 12:31 | CC:PMN | Promis Neurosciences Inc (2) | 5.00 | News Release200 | Promis shareholders approve all matters at AGM |
| 2023-05-15 17:44 | CC:PMN | Promis Neurosciences Inc (2) | 7.81 | News Release200 | Promis has March 31 cash position of $3.3M (U.S.) |
| 2023-05-15 17:21 | CC:PMN | Promis Neurosciences Inc (2) | 7.81 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-05-15 17:15 | CC:PMN | Promis Neurosciences Inc (2) | 7.81 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-05-08 10:46 | CC:PMN | Promis Neurosciences Inc (2) | 8.92 | News Release200 | Promis receives FDA clearance of PMN310 IND application |